Amylyx Pharmaceuticals Growth Metrics (2022-2025) | AMLX

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -0.78M1.59M0.02M-0.01M-0.75M-1.82M-3.17M
EBITDA Margin Growth (3y) (Quarter) -1.01M
EBITDA Margin (QoQ) (Quarter) 1.56M0.02M0.00M-41.00-0.00M-0.01M-0.73M-1.07M-1.35M
EBIT Margin Growth (1y) (Quarter) -0.78M1.59M0.02M-0.01M-0.75M-1.82M-3.17M
EBIT Margin Growth (3y) (Quarter) -1.01M
EBIT Margin (QoQ) (Quarter) 1.56M0.02M0.00M-41.00-0.00M-0.01M-0.73M-1.07M-1.35M
EBT Margin Growth (1y) (Quarter) -0.75M1.56M-0.07M-0.01M-0.71M-1.75M-3.96M
EBT Margin Growth (3y) (Quarter) -0.94M
EBT Margin (QoQ) (Quarter) 1.63M-0.07M0.00M-32.00-0.00M-0.01M-0.70M-1.04M-2.22M
Enterprise Value Growth (1y) (Quarter) -260.96%-35.45%-72.86%-118.36%-7.04%-7.99%13.28%33.98%52.47%45.33%41.63%-46.76%-79.59%
Enterprise Value Growth (3y) (Quarter) -22.46%7.18%4.36%-28.38%2.97%
Enterprise Value (QoQ) (Quarter) -165.51%19.01%21.33%-113.38%0.37%-3.36%0.62%-4.60%-0.52%17.01%24.34%24.70%-15.62%11.39%-90.23%7.85%
FCF Margin Growth (1y) (Quarter) -0.52M1.26M0.02M682.00-0.65M-1.00M0.89M
FCF Margin Growth (3y) (Quarter) -0.26M
FCF Margin (QoQ) (Quarter) 1.24M0.02M0.00M-0.00M0.00M-0.00M-0.65M-0.35M1.89M
Gross Margin Growth (1y) (Quarter) 0.00M426.0069.00437.00508.00863.00
Gross Margin (QoQ) (Quarter) 0.00M549.00225.007.00-355.00192.00592.0078.000.00M
Net Margin Growth (1y) (Quarter) -0.75M1.56M-0.07M-0.01M-0.71M-1.75M-3.98M
Net Margin Growth (3y) (Quarter) -0.94M
Net Margin (QoQ) (Quarter) 1.63M-0.07M0.00M-2.00-0.00M-0.01M-0.70M-1.04M-2.23M
Operating Margin Growth (1y) (Quarter) -0.78M1.59M0.02M-0.01M-0.75M-1.82M-3.17M
Operating Margin Growth (3y) (Quarter) -1.01M
Operating Margin (QoQ) (Quarter) 1.56M0.02M0.00M-41.00-0.00M-0.01M-0.73M-1.07M-1.35M
Return on Assets Growth (1y) (Quarter) 0.00M1.001.000.00M0.00M-1.00-1.000.00M1.001.001.000.00M
Return on Assets Growth (3y) (Quarter) 1.001.001.000.00M
Return on Assets (QoQ) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M1.000.00M0.00M0.00M-1.00
Return on Capital Employed Growth (1y) (Quarter) 0.00M0.00M0.01M0.01M0.00M-0.00M-0.01M-0.00M0.00M0.01M0.02M-0.00M
Return on Capital Employed Growth (3y) (Quarter) 0.01M0.01M0.01M0.00M
Return on Capital Employed (QoQ) (Quarter) 363.00-0.00M0.00M0.00M0.00M0.00M0.00M-0.00M-0.00M-0.01M0.01M0.00M0.00M791.00-0.01M
Return on Equity Growth (1y) (Quarter) 0.00M1.001.001.000.00M0.00M-1.00-2.000.00M1.001.002.000.00M
Return on Equity Growth (3y) (Quarter) 0.00M1.001.001.000.00M
Return on Equity (QoQ) (Quarter) -1.000.00M0.00M1.000.00M0.00M0.00M0.00M0.00M0.00M-1.001.000.00M0.00M0.00M-1.00
Return on Invested Capital Growth (1y) (Quarter) 0.00M0.00M0.00M-1.000.00M0.00M1.002.00-1.00
Return on Invested Capital Growth (3y) (Quarter) 0.00M
Return on Invested Capital (QoQ) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M-1.001.000.00M0.00M0.00M-1.00
Return on Sales Growth (1y) (Quarter) -75.00156.00-7.00-1.00-71.00-175.00-398.00109.00-388.00-55.00
Return on Sales Growth (3y) (Quarter) -94.00-74.00
Return on Sales (QoQ) (Quarter) 163.00-7.000.00M0.00M0.00M-1.00-70.00-104.00-223.00505.00-567.00230.00